Akzo Nobel NV AKZO NOBEL ORD SHS/ NL0013267909 /
| 2024-04-18 1:01:35 PM | Chg. -1.25 | Volume | Bid2024-04-18 | Ask2024-04-18 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 65.88EUR | -1.86% | 3,230 Turnover: 121,800.80 |
62.66Bid Size: 1,000 | 69.24Ask Size: 1,000 | 11.23 bill.EUR | 3.01% | 25.12 |
GlobeNewswire
04-16
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at Natio...
GlobeNewswire
04-13
C.K. McWhorter Endows Wimbledon Championships With Esteemed McWhorter Family Trust Warrant Of Excell...
GlobeNewswire
04-11
C.K. McWhorter Calls On Prince William in an Effort to Redirect Global Defense Spending Towards Huma...
GlobeNewswire
04-05
CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire
04-03
Alliance for Decision Education Recognized as One of The NonProfit Times’ Best Nonprofits to Work Fo...
GlobeNewswire
04-03
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
GlobeNewswire
04-02
Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Pres...
GlobeNewswire
04-01
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Me...
GlobeNewswire
03-29
UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Can...
GlobeNewswire
03-26
Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
GlobeNewswire
03-22
Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global ...
GlobeNewswire
03-19
Alliance for Decision Education Secures $12.5M in Funding to Expand Decision Education Research
GlobeNewswire
03-19
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
GlobeNewswire
03-19
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
